Hematopoietic recovery. Analysis was performed in the as-treated population (n = 108). Cumulative incidence of neutrophil engraftment by day 42 (A) and platelet recovery by day 100 (B) among recipients of omidubicel or unmanipulated UCB.
Figure 3.

Hematopoietic recovery. Analysis was performed in the as-treated population (n = 108). Cumulative incidence of neutrophil engraftment by day 42 (A) and platelet recovery by day 100 (B) among recipients of omidubicel or unmanipulated UCB.

This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal